These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26096975)

  • 1. Reward Pays the Cost of Noise Reduction in Motor and Cognitive Control.
    Manohar SG; Chong TT; Apps MA; Batla A; Stamelou M; Jarman PR; Bhatia KP; Husain M
    Curr Biol; 2015 Jun; 25(13):1707-16. PubMed ID: 26096975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
    Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation.
    Mazzoni P; Hristova A; Krakauer JW
    J Neurosci; 2007 Jul; 27(27):7105-16. PubMed ID: 17611263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivation dynamically increases noise resistance by internal feedback during movement.
    Manohar SG; Muhammed K; Fallon SJ; Husain M
    Neuropsychologia; 2019 Feb; 123():19-29. PubMed ID: 30005926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical Decision-Making: A Framework for Understanding Cognition in Parkinson's Disease.
    Perugini A; Ditterich J; Shaikh AG; Knowlton BJ; Basso MA
    Trends Neurosci; 2018 Aug; 41(8):512-525. PubMed ID: 29747856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine restores cognitive motivation in Parkinson's disease.
    McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
    Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motivation-cognition interaction: how feedback processing changes in healthy ageing and in Parkinson's disease.
    Di Rosa E; Schiff S; Cagnolati F; Mapelli D
    Aging Clin Exp Res; 2015 Dec; 27(6):911-20. PubMed ID: 25854302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
    Chen X; Voets S; Jenkinson N; Galea JM
    J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine function and the efficiency of human movement.
    Gepshtein S; Li X; Snider J; Plank M; Lee D; Poizner H
    J Cogn Neurosci; 2014 Mar; 26(3):645-57. PubMed ID: 24144250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
    Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
    Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Dissection of Dopamine Motor and Motivational Functions in Humans.
    Le Bouc R; Rigoux L; Schmidt L; Degos B; Welter ML; Vidailhet M; Daunizeau J; Pessiglione M
    J Neurosci; 2016 Jun; 36(25):6623-33. PubMed ID: 27335396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic influences on risk preferences of Parkinson's disease patients.
    Kobayashi S; Asano K; Matsuda N; Ugawa Y
    Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
    Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
    J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine promotes instrumental motivation, but reduces reward-related vigour.
    Grogan JP; Sandhu TR; Hu MT; Manohar SG
    Elife; 2020 Oct; 9():. PubMed ID: 33001026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
    Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
    Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced motivation of cognitive control in Parkinson's disease.
    Timmer MHM; Aarts E; Esselink RAJ; Cools R
    Eur J Neurosci; 2018 Sep; 48(6):2374-2384. PubMed ID: 30151991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive capacity limitations and Need for Cognition differentially predict reward-induced cognitive effort expenditure.
    Sandra DA; Otto AR
    Cognition; 2018 Mar; 172():101-106. PubMed ID: 29247878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine enhances willingness to exert effort for reward in Parkinson's disease.
    Chong TT; Bonnelle V; Manohar S; Veromann KR; Muhammed K; Tofaris GK; Hu M; Husain M
    Cortex; 2015 Aug; 69():40-6. PubMed ID: 25967086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.